|
|
ix | |
|
SECTION 1 Background and Basics |
|
|
|
1 The epidemiology and pathophysiology of coronary artery disease |
|
|
3 | (12) |
|
|
|
2 The history of interventional cardiology |
|
|
15 | (10) |
|
|
|
|
3 Risk assessment and analysis of outcomes |
|
|
25 | (24) |
|
|
4 Vascular access: femoral versus radial |
|
|
49 | (16) |
|
|
|
5 Radiation and percutaneous coronary intervention |
|
|
65 | (10) |
|
|
|
6 The `golden rules' of percutaneous coronary intervention |
|
|
75 | (6) |
|
|
7 Care following percutaneous coronary intervention |
|
|
81 | (10) |
|
|
|
|
8 Trial design and interpretation in interventional cardiology: why is evidence-based medicine important? |
|
|
91 | (8) |
|
|
|
SECTION 2 Percutaneous Coronary Intervention-related Imaging |
|
|
|
9 Angiography: indications and limitations |
|
|
99 | (28) |
|
|
|
|
10 Coronary physiology in clinical practice |
|
|
127 | (18) |
|
|
|
|
11 The role of intravascular ultrasound in percutaneous coronary intervention |
|
|
145 | (26) |
|
|
|
|
12 Intravascular ultrasound and optical coherence tomography in percutaneous coronary intervention |
|
|
171 | (6) |
|
|
|
|
13 Cardiac computed tomography for the interventionalist |
|
|
177 | (14) |
|
|
|
|
|
14 Cardiovascular magnetic resonance |
|
|
191 | (20) |
|
|
|
SECTION 3 Percutaneous Coronary Intervention by Clinical Syndrome |
|
|
|
15 Stable coronary disease: medical therapy versus percutaneous coronary intervention versus surgery |
|
|
211 | (24) |
|
|
|
16 Percutaneous coronary intervention in non-ST elevation acute coronary syndrome |
|
|
235 | (16) |
|
|
|
|
17 Primary percutaneous coronary intervention for ST-elevation myocardial infarction |
|
|
251 | (22) |
|
|
|
18 Percutaneous coronary intervention in patients with impaired left ventricular function |
|
|
273 | (14) |
|
|
|
SECTION 4 Percutaneous Coronary Intervention by Lesion and Patient Subsets |
|
|
|
19 Coronary bifurcation stenting: state of the art |
|
|
287 | (18) |
|
|
|
|
|
|
20 Percutaneous coronary intervention for left main coronary artery stenosis |
|
|
305 | (10) |
|
|
|
|
|
|
21 Chronic total occlusions |
|
|
315 | (22) |
|
|
|
|
22 Revascularization in patients with diabetes mellitus |
|
|
337 | (14) |
|
|
|
23 Out-of-hospital cardiac arrest: role of percutaneous coronary intervention |
|
|
351 | (12) |
|
|
|
SECTION 5 Adjunctive Drug Therapies in Percutaneous Coronary Intervention |
|
|
|
24 Oral antiplatelet therapies in percutaneous coronary intervention |
|
|
363 | (18) |
|
|
|
|
25 Current status of glycoprotein IIb/IIIa inhibitors |
|
|
381 | (20) |
|
|
26 The role of bivalirudin in percutaneous coronary intervention |
|
|
401 | (16) |
|
|
|
|
27 Optimal medical therapy in percutaneous coronary intervention patients: statins and angiotensin-converting enzyme inhibitors as disease-modifying agents |
|
|
417 | (16) |
|
|
|
28 New oral anticoagulants: the evidence base and role in patients undergoing percutaneous coronary intervention |
|
|
433 | (14) |
|
|
|
|
SECTION 6 Complications of Percutaneous Coronary Intervention |
|
|
|
29 Contrast-induced acute kidney injury |
|
|
447 | (6) |
|
|
30 In-stent restenosis in the drug-eluting stent era |
|
|
453 | (20) |
|
|
|
|
|
|
|
473 | (28) |
|
|
|
|
32 Stent loss and retrieval |
|
|
501 | (10) |
|
|
|
33 Coronary artery perforation |
|
|
511 | (14) |
|
|
|
SECTION 7 Special Devices in Percutaneous Coronary Intervention |
|
|
|
34 Rotational atherectomy |
|
|
525 | (10) |
|
|
|
|
|
535 | (22) |
|
|
|
36 No-reflow in native coronaries and vein grafts: the role of drugs and distal protection |
|
|
557 | (12) |
|
|
|
37 Bioresorbable vascular scaffolds |
|
|
569 | (14) |
|
|
|
38 Access routes and the transcatheter aortic valve implantation procedure |
|
|
583 | (6) |
|
|
|
|
39 Selection of transcatheter aortic valve implantation prostheses |
|
|
589 | (12) |
|
|
|
40 Transcatheter aortic valve implantation and the management of coronary artery disease |
|
|
601 | (6) |
|
|
|
41 Transcatheter mitral valve repair |
|
|
607 | (22) |
|
|
|
42 Transcatheter mitral valve replacement |
|
|
629 | (12) |
|
|
|
|
|
SECTION 8 Non-coronary Percutaneous Interventions |
|
|
|
43 Percutaneous device closure of atrial septal defect and patent foramen ovale |
|
|
641 | (16) |
|
|
|
|
|
44 Mitral balloon valvuloplasty |
|
|
657 | (12) |
|
|
|
|
|
|
45 Alcohol septal ablation for obstructive hypertrophic cardiomyopathy |
|
|
669 | (12) |
|
|
|
|
46 Carotid artery stenting |
|
|
681 | (22) |
|
|
|
47 Left atrial appendage occlusion |
|
|
703 | (14) |
|
|
|
|
|
|
48 Novel device therapies for resistant hypertension |
|
|
717 | (14) |
|
|
|
|
49 Robotic percutaneous coronary intervention |
|
|
731 | (6) |
|
|
50 Stem cell delivery and therapy |
|
|
737 | (14) |
|
|
Index |
|
751 | |